<VariationArchive VariationID="2203107" VariationName="NM_006302.3(MOGS):c.832_833del (p.Lys278fs)" VariationType="Deletion" Accession="VCV002203107" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-14" DateCreated="2023-02-08" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1925335" VariationID="2203107">
      <GeneList>
        <Gene Symbol="MOGS" FullName="mannosyl-oligosaccharide glucosidase" GeneID="7841" HGNC_ID="HGNC:24862" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="74461057" stop="74465382" display_start="74461057" display_stop="74465382" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="74688183" stop="74692536" display_start="74688183" display_stop="74692536" Strand="-" />
          </Location>
          <OMIM>601336</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_006302.3(MOGS):c.832_833del (p.Lys278fs)</Name>
      <CanonicalSPDI>NC_000002.12:74462955:TTT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="74462956" stop="74462957" display_start="74462956" display_stop="74462957" variantLength="2" positionVCF="74462955" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="74690083" stop="74690084" display_start="74690083" display_stop="74690084" variantLength="2" positionVCF="74690082" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K172fs</ProteinChange>
      <ProteinChange>K278fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.74690084_74690085del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.74690084_74690085del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.74462957_74462958del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.74462957_74462958del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008922.1" sequenceAccession="NG_008922" sequenceVersion="1" change="g.7454_7455del">
            <Expression>NG_008922.1:g.7454_7455del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001146158.2" sequenceAccession="NM_001146158" sequenceVersion="2" change="c.514_515del">
            <Expression>NM_001146158.2:c.514_515del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001139630.1" sequenceAccession="NP_001139630" sequenceVersion="1" change="p.Lys172fs">
            <Expression>NP_001139630.1:p.Lys172fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006302.3" sequenceAccession="NM_006302" sequenceVersion="3" change="c.832_833del" MANESelect="true">
            <Expression>NM_006302.3:c.832_833del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006293.2" sequenceAccession="NP_006293" sequenceVersion="2" change="p.Lys278fs">
            <Expression>NP_006293.2:p.Lys278fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1226" sequenceAccession="LRG_1226">
            <Expression>LRG_1226:g.7454_7455del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1226t1" sequenceAccession="LRG_1226t1">
            <Expression>LRG_1226t1:c.832_833del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1226p1" sequenceAccession="LRG_1226p1" change="p.Lys278fs">
            <Expression>LRG_1226p1:p.Lys278fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006302.3(MOGS):c.832_833del (p.Lys278fs) AND MOGS-congenital disorder of glycosylation" Accession="RCV002664245" Version="2">
        <ClassifiedConditionList TraitSetID="2251">
          <ClassifiedCondition DB="MedGen" ID="C1853736">MOGS-congenital disorder of glycosylation</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-01-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">30587846</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2251" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4838" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CDG 2B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MOGS-CDG</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital disorder of glycosylation type 2B</ElementValue>
                <XRef ID="CONGENITAL+DISORDER+OF+GLYCOSYLATION%2C+TYPE+IIb/8057" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CDG IIb</ElementValue>
                <XRef Type="MIM" ID="606056" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLUCOSIDASE I DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="606056" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">MOGS-congenital disorder of glycosylation</ElementValue>
                <XRef ID="MONDO:0011629" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CDG2B</ElementValue>
                <XRef Type="MIM" ID="606056" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CDGIIb</ElementValue>
                <XRef Type="MIM" ID="606056" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10767" />
                <XRef ID="10767" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301507</ID>
                <ID Source="BookShelf">NBK1332</ID>
              </Citation>
              <XRef ID="79330" DB="Orphanet" />
              <XRef ID="C1853736" DB="MedGen" />
              <XRef ID="MONDO:0011629" DB="MONDO" />
              <XRef Type="MIM" ID="606056" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="6213865" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4831322|MedGen:C1853736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003524726" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30587846</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the MOGS protein in which other variant(s) (p.Asp414Leufs*17) have been determined to be pathogenic (PMID: 30587846). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with MOGS-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys278Glufs*5) in the MOGS gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 560 amino acid(s) of the MOGS protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MOGS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.74690083_74690084del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1853736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6213865" TraitType="Disease" MappingType="XRef" MappingValue="C1853736" MappingRef="MedGen">
        <MedGen CUI="C1853736" Name="MOGS-congenital disorder of glycosylation" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

